NeuroCME
LECTURECMECNE

Highlights from MS Forum® V

Author(s)/Faculty: Patricia K. Coyle, MD, FAAN, FANA; Guy J. Buckle, MD, MPH; Bruce A. Cohen, MD, FAAN, FANA, FACP; Clyde E. Markowitz, MD; Harold Moses, MD
Release Date: 12/31/2018Expiration Date: 12/30/2019
Credit Type: CME / CNENumber of Credits: 1.75
Content Type: LectureProvider:
Multiple sclerosis (MS) is a chronic, often disabling disease that attacks the central nervous system. The management of patients with MS is highly complex and the development of disease-modifying therapies (DMTs) has dramatically altered the treatment paradigm. Guidelines from the American Academy of Neurology on the use of DMTs were just released in 2018 and clinicians need to be updated on these new evidence-based recommendations. In this CME/CNE activity, Highlights from MS Forum® V, current treatment guidelines, safety, efficacy, and use of current DMTs will be discussed.